4.5 Review

B cells in multiple sclerosis

Journal

FRONTIERS IN BIOSCIENCE-LANDMARK
Volume 9, Issue -, Pages 786-796

Publisher

FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/1278

Keywords

multiple sclerosis; MS; B cells; antibodies; oligoclonal bands; review; CNS; central nervious system; neurologic disease; review

Funding

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041549, P01NS032623] Funding Source: NIH RePORTER
  2. NINDS NIH HHS [NS 32623, NS 41549, P01 NS032623, R01 NS041549, R01 NS041549-03] Funding Source: Medline

Ask authors/readers for more resources

The most common laboratory abnormality in multiple sclerosis (MS) is an increased amount of cerebrospinal fluid IgG and the presence of oligoclonal bands. Despite studies of the humoral response that suggest the involvement of an infectious agent or autoantigen in disease, the major targets of the oligoclonal response are still unknown. Identification of these targets will reveal valuable insights into the cause and pathogenesis of MS and is likely to lead to effective treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available